[Therapeutic use of a new drug association with antispastic action].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000480:Alkynes / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use; D001660:Biliary Tract Diseases / Q000188:drug therapy*; D003108:Colonic Diseases / Q000188:drug therapy; D011431:Dextropropoxyphene / Q000627:therapeutic use*; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy; D005260:Female; D005756:Gastritis / Q000188:drug therapy; D005759:Gastroenteritis / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D013035:Spasm / Q000188:drug therapy; D014326:Tropanes / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000480:Alkynes; D009125:Muscle Relaxants, Central; D014326:Tropanes; D001285:Atropine; D011431:Dextropropoxyphene
Impiego terapeutico di una nuova associazione ad azione antispastica.